Back to home
TECH logo

Is TECH (Bio-Techne Corporation) Halal or Haram?

NASDAQ Global SelectHealthcareBiotechnology$8.37B2026-04-29
TECH is Halal4/4 screens passed

Bio-Techne Corporation comfortably passes all AAOIFI shariah screening criteria with exceptional financial purity. The company maintains a very conservative debt-to-market cap ratio of 5.3%, well below the 33% threshold, and generates a negligible 0.32% of its revenue from interest-bearing activities. With cash and securities at just 1.9% of its market cap, TECH represents a robust, fully compliant biotechnology option for halal portfolios.

Price Chart (5D)

$54.99+0.40 (+0.73%)
2026-05-012026-04-24

TECH — Last 7 Days

DateOpenHighLowCloseVolumeChange
2026-05-0155.0855.6453.5855.022.0M-0.11%
2026-04-3052.4255.9351.9055.323.5M+5.53%
2026-04-2953.0453.7451.0351.951.4M-2.06%
2026-04-2855.0055.2952.9953.511.6M-2.71%
2026-04-2754.2955.5053.7755.111.5M+1.51%
2026-04-2452.5354.7452.0554.192.0M+3.16%
2026-04-2357.5257.5751.1352.203.3M-9.25%

Discussion

Sign in to join the discussion

Loading comments...

Shariah Screening Details for TECH

Business Activity

Permissible

Bio-Techne Corporation's business of developing life science reagents, clinical diagnostics, and cell therapy technologies is permissible and aligns with Islamic principles of promoting health and scientific advancement.

Debt / Market Cap

5.30%

Debt: $444.1MThreshold: ≤33%

Interest Income

0.32%

Interest: $3.9MThreshold: ≤5%

Cash & Securities

1.94%

Cash: $162.2MThreshold: ≤33%

About Bio-Techne Corporation (TECH)

Bio-Techne Corporation is a key player in the biotechnology sector, specializing in life science reagents, instruments, and clinical diagnostic services. The company primarily operates through its Protein Sciences and Diagnostics and Genomics segments, providing essential tools like cytokines, antibodies, and cell selection technologies used in cutting-edge research and gene therapy.

For Muslim investors, Bio-Techne represents a strong Halal investment opportunity, having successfully passed all AAOIFI screening criteria. The company's core operations in healthcare and scientific research are highly beneficial and fully permissible, ensuring your investment supports ethical, life-saving advancements without engaging in prohibited industries.

From an Islamic finance perspective, Bio-Techne's financial structure is exceptionally clean. The company boasts a remarkably low debt-to-market cap ratio of just 5.3%, alongside minimal interest income representing only 0.32% of total revenue, meaning investors do not have to worry about excessive leverage or non-permissible earnings.

While there are no current scholarly debates regarding Bio-Techne's compliance, halal investors should continue to monitor its future acquisitions. As the company expands its diagnostics and genomics portfolio, ensuring new subsidiaries maintain this strict financial purity will be key to long-term shariah compliance.

CEO

Kim Kelderman

Employees

3,100

IPO Date

1989-02-09

Headquarters

Minneapolis, MN, US

TECH Key Financial Statistics

Revenue

$1.22B

Net Income

$73.4M

EPS (Diluted)

$0.46

Stock Price

53.51

Beta

1.49

52-Week Range

46.05-72.16

Total Debt

$444.1M

Total Equity

$1.92B

Current Ratio

3.46

TECH Financial Health & Profitability

Profit Margins

Gross Margin64.8%
Operating Margin8.4%
Net Margin6.0%

Revenue Growth (YoY)

+5.2%

Prior year: $1.16B

Net Debt

$281.9M

Cash: $162.2M — Debt: $444.1M

R&D Spending

$99.5M

% of Revenue

8.2%

Frequently Asked Questions About TECH

Is TECH (Bio-Techne Corporation) stock halal to invest in?
Based on our AAOIFI-standard shariah screening, TECH is Halal and considered permissible for Muslim investors. It passed all 4 of 4 compliance screens including business activity review, debt-to-market-cap ratio (5.30% vs ≤33% threshold), interest income ratio (0.32% vs ≤5% threshold), and cash & securities ratio (1.94% vs ≤33% threshold).
What does Bio-Techne Corporation do?
Bio-Techne Corporation is a key player in the biotechnology sector, specializing in life science reagents, instruments, and clinical diagnostic services. The company primarily operates through its Protein Sciences and Diagnostics and Genomics segments, providing essential tools like cytokines, antibodies, and cell selection technologies used in cutting-edge research and gene therapy. For Muslim investors, Bio-Techne represents a strong Halal investment opportunity, having successfully passed all AAOIFI screening criteria. The company's core operations in healthcare and scientific research are highly beneficial and fully permissible, ensuring your investment supports ethical, life-saving advancements without engaging in prohibited industries. From an Islamic finance perspective, Bio-Techne's financial structure is exceptionally clean. The company boasts a remarkably low debt-to-market cap ratio of just 5.3%, alongside minimal interest income representing only 0.32% of total revenue, meaning investors do not have to worry about excessive leverage or non-permissible earnings. While there are no current scholarly debates regarding Bio-Techne's compliance, halal investors should continue to monitor its future acquisitions. As the company expands its diagnostics and genomics portfolio, ensuring new subsidiaries maintain this strict financial purity will be key to long-term shariah compliance. Bio-Techne Corporation operates in the Healthcare sector under the Biotechnology industry and is headquartered in Minneapolis, MN, US. The company is led by CEO Kim Kelderman and employs approximately 3,100 people.
What screening criteria were used for TECH?
TECH was screened using AAOIFI-based shariah compliance criteria. Four tests are applied: (1) Business Activity — the company's core business must not derive primary income from haram (prohibited) activities such as alcohol, gambling, tobacco, or interest-based finance. (2) Debt-to-Market-Cap — total debt must not exceed 33% of market capitalization. (3) Interest Income — interest income must not exceed 5% of total revenue. (4) Cash & Securities — cash and interest-bearing securities must not exceed 33% of market cap. TECH passed 4 of these 4 screens.
Does TECH require income purification?
Although TECH passes all shariah screens, it does earn $3.9M in interest income (0.32% of revenue). Many scholars recommend purifying this portion by donating the equivalent percentage of any dividends received to charity. For example, if you receive $100 in dividends, you would donate approximately $0.32 to purify the income.
When was TECH last screened?
TECH was last screened on 2026-04-29. Shariah compliance status can change as companies report new financial data, acquire new businesses, or shift revenue streams. We recommend checking back periodically for the most up-to-date screening results.

Disclaimer

This shariah compliance assessment for TECH (Bio-Techne Corporation) is provided for informational purposes only and does not constitute financial, investment, or religious advice. Screening criteria are based on widely accepted AAOIFI standards, but individual scholars may differ in their opinions. Always consult with a qualified Islamic scholar and licensed financial advisor before making investment decisions. Past screening status does not guarantee future compliance. Last screened: 2026-04-29.

Other Halal Stocks in Healthcare